Has Abdulaziz Alali, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,569 in general payments to Abdulaziz Alali, MD across 165 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abdulaziz Alali, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abdulaziz Alali, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abdulaziz Alali, MD

Neurological Surgery · Seattle, WANPI 1881104164

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Retropsoas Technologies, LLC at 56.8% of the total. Reporting peaked in 2022 at $6,519 and has fallen 92.6% since, to $481 in 2025.

$10,569in general payments, 2019–2025

Across 165 payments — averaging $64.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Retropsoas Technologies, LLC$6K
Medtronic$4K
Stryker$588
Amgen$115
Abbott$71

What the payments were for

Consulting fees$6,00057%
Travel & lodging$6176%
Food & beverage$3,95237%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Retropsoas Technologies, LLC	1	$6,000
Medtronic(2 entities)	151	$3,795
Stryker	10	$588
Amgen	2	$115
Abbott	1	$71

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,569 in reported general payments places this provider in the 75th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$338,127

Medicare patients

325

Services billed

813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naloxone Hcl	22	$1,379
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	56	$839
Cyclobenzaprine Hcl	28	$148
Diazepam	18	$55
Tramadol Hcl	15	$46

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Seattle

Rod OskouianSeattle$2.4M
Christoph HofstetterSeattle$768K
Stephen MonteithSeattle$151K
Jean-Christophe LevequeSeattle$120K
Vijay YanamadalaSeattle$85K
Hoan Vu TranSeattle$78K
Martin RutkowskiSeattle$62K
Bailey ZampellaSeattle$38K
Melanie WalkerSeattle$38K
Elias EliasSeattle$35K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →